Table 4.
Comparison of Subjects With and Without the Endpoint of HF Hospitalization or Death
| No HF or Death | Yes HF or Death | ||||
|---|---|---|---|---|---|
| Variable | N | Median | N | Median | p-value |
| Age (yrs) | 90 | 57 | 44 | 59.5 | 0.53 |
| IL-6 (pg/mL) | 90 | 3.1 | 44 | 4.5 | 0.06 |
| TNFα (pg/mL) | 90 | 4.3 | 44 | 6 | 0.02 |
| cTnI (pg/mL) | 90 | 7.4 | 44 | 14.2 | 0.005 |
| VEGF(pg/mL) | 90 | 35.3 | 44 | 46.3 | 0.04 |
| CRP (mg/L) | 88 | 3.5 | 42 | 4.6 | 0.54 |
| CT-ET1 (pmol/L) | 90 | 72.3 | 44 | 110 | <.0001 |
| Sgx-ET1 (pg/mL) | 90 | 4.1 | 44 | 5.2 | <.0001 |
| NTproBNP (pg/mL) | 90 | 980 | 44 | 3019 | <.0001 |